Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Compare volatility and returns in retirement index funds to strike a balance between potential growth and risk control for sustainable withdrawals.
24,638 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
A year after GameStop added bitcoin to its treasury, the company reports a sizable impairment on digital assets amid ...
Regional disparities in the Iran conflict determine how households budget for energy, groceries, and bills. A new Oxf...
When a mining stock pops, traders look beyond a single catalyst. This article breaks down why coeur mining stock popp...
IonQ is leading the field among pure-play quantum stocks in 2026, delivering a positive year-to-date return while its...
As confirmation hearings approach, kevin warsh’s undisclosed wealth becomes a flashpoint, with a 69-page filing leavi...
Caris Life Sciences blends lab testing with AI-driven insights to tackle oncology challenges. This piece breaks down ...
A speculative bid by GameStop to purchase eBay sparks fresh debate about stock-based deals and the risk of overpaying...
Bitcoin and XRP led a crypto rally after a Trump Iran-focused post, with BTC moving higher and XRP testing multi-week...
NXT starts trading on four leading exchanges, fueling an on-chain AI entertainment ecosystem. The rollout highlights ...
QuantumScape stock rallies on the Eagle Line milestone and early customer billings, signaling a shift from research t...
Malaysian authorities reveal Iranian-linked vessels are swapping sanctioned oil in offshore zones near Johor, raising...